null

SMILES CCNC1(CN(C1)c1cnc(-c2ccc(cc2)C(F)(F)F)c(n1)-c1ccnc(Cl)c1)C(N)=O

InChI Key InChIKey=YSPBHPREQBXDKT-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50260803   

TargetCannabinoid receptor 1(Homo sapiens (Human))
Neurogen Corporation

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)copy SMILEScopy InChI
Affinity DataKi:  1.20nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2QR4Z0TPubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Neurogen Corporation

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)copy SMILEScopy InChI
Affinity DataKi:  2.06nMAssay Description:Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2QR4Z0TPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Neurogen Corporation

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)copy SMILEScopy InChI
Affinity DataKi: >5.00E+4nMAssay Description:Antagonist activity at human CB2 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2QR4Z0TPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Neurogen Corporation

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)copy SMILEScopy InChI
Affinity DataIC50: 3.07nMAssay Description:Inverse agonist at human CB1 receptor expressed in SF9 cells assessed as decrease in GTPgammaS levelMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2QR4Z0TPubMed